top of page
Miguel Prudêncio Lab, iMM, 2020
PbVac, a new (chimeric) class of agents for whole-organism vaccination against malaria, based on the modification of the rodent parasite genetically engineered to express a strongly immunogenic human malaria parasite protein.


Marc Veldhoen Lab, iMM, 2020
bottom of page